Company's Lead Joint Researcher Professor Perán to Present Latest PRP Research Propanc Biopharma, Inc. (OTC Pink: PPCB) ("Propanc" or the "Company"), a biopharmaceutical company developing novel
The European Patent Office (EPO) celebrates the best and most innovative breakthroughs in its annual European Inventor Award, which will take place in a virtual ceremony on 21 June.
Nachhaltige Finanzanlagen werden bei Anlegern immer beliebter. Die EU-Kommission streitet darüber, ob auch Atomenergie als nachhaltig gelten soll. Die deutsche Fondsbranche ist sich ebenfalls uneins.
Current Research Shows Proenzymes Decreases Cell Proliferation and Migration, Induces Cell Differentiation, Impairs Angiogenesis and Reduces the Metastatic Potential of Cancer Stem CellsMELBOURNE, Australia (BUSINESS WIRE) Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering